Tech Company Financing Transactions

Hypnion Funding Round

On 3/17/2003, Hypnion landed $47.5 million in Series B funding from Forward Ventures, MPM Capital and Advanced Technology Ventures.

Transaction Overview

Company Name
Announced On
3/17/2003
Transaction Type
Venture Equity
Amount
$47,500,000
Round
Series B
Investors

Forward Ventures (Lead Investor) (Joel Martin)

MPM Capital (Lead Investor) (Nick Galakatos)

Advanced Technology Ventures (Jean George)

Oxford Bioscience Partners

Rally Ventures

Proceeds Purpose
Hypnion expects to enter clinical trials with several proprietary compounds that have superior preclinical efficacy and safety compared to the current market leaders in sleep and wake promotion.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
500 Patriot Way
Lexington, MA 02421
USA
Email Address
Overview
Hypnion is a privately held drug discovery company developing novel therapeutics for the treatment of central nervous system (CNS) disorders.
Profile
Hypnion LinkedIn Company Profile
Social Media
Hypnion Company Twitter Account
Company News
Hypnion News
Facebook
Hypnion on Facebook
YouTube
Hypnion on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Dee
  John Dee LinkedIn Profile  John Dee Twitter Account  John Dee News  John Dee on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/17/2003: LeftHand Networks venture capital transaction
Next: 3/18/2003: Brickstream venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary